Rehab Station Stockholm
Stockholm, Sweden
NCT Number: NCT07473258
The goal of this clinical trial is to learn if a 10-week web-based health promotion program ("DRIV") can improve healthy lifestyle habits and overall well-being in adults living with long-term spinal cord injury (SCI). The main questions it aims to answer are:
Does participating in the online course lead to healthier lifestyle behaviors (for example, more physical activity and a better diet) and improved self-reported health for people with SCI? Are any improvements in health habits or well-being maintained six months after completing the program?
Researchers will compare participants who take the 10-week DRIV course to those on a waitlist (no intervention during that period) to see if any changes in lifestyle or health outcomes are due to the program (and not just time or other factors).
Participants will:
Attend a 1-hour group session online (via video) each week for 10 weeks, covering topics like exercise, nutrition, stress management, and goal setting (this is the intervention for the course group; waitlist group has no sessions during this time).
Complete health questionnaires at the start of the study and after 10 weeks (all participants), and again 6 months after the course for those who received the intervention, to report on their lifestyle habits, physical and mental health, and goal achievement.
Wear a wrist activity monitor (accelerometer) for 7 days at the beginning and 7 days at the end of the 10-week period to objectively measure physical activity levels.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Stockholm, Sweden
Overview This study evaluates the DRIV program, a 10-week web-based health-promotion course designed for individuals living long-term with spinal cord injury (SCI). The Detailed Description below outlines the study's operational procedures, design, data-collection flow, and analytic approach. It intentionally avoids content already provided in sections such as background, significance, eligibility criteria, and outcome measures.
Study Design The study uses a prospective intervention design with a waitlist control group. All individuals who register for the DRIV course are placed on a waitlist. For each course cycle, 8-12 individuals are invited to participate in that round and make up the intervention cohort. Individuals remaining on the waitlist are invited to serve as controls, with the guarantee that they will later be offered participation in a future course cycle.
Participants are not blinded to their group assignment, as the intervention consists of an educational course requiring active engagement.
Intervention Procedures
The intervention is the 10-week DRIV online course, delivered via Zoom. Each weekly session includes:
A topic-specific lecture (e.g., adapted physical activity, nutrition, stress management).
Facilitated discussions based on a study-circle model. Structured goal-setting and behavioral-change strategies. Weekly home assignments and optional adapted exercise sessions.
All course participants (regardless of research participation) receive identical program content. Study participants additionally complete standardized assessments at specified timepoints.
Control Procedures Control participants receive no intervention during their 10-week control period and continue their usual activities. They complete the same baseline and 10-week assessments as the intervention group, allowing comparison of changes over an equivalent time frame. Once their control period ends, they are offered a place in the next DRIV course but are not included again as new study controls.
Measurement Schedule
Study participants complete assessments at the following timepoints:
All assessments are self-administered digitally via REDCap. Participants in both groups wear an accelerometer for 7 days at T1 and T2; only intervention participants repeat this at T3.
Data Collection Procedures
No identifiable data are stored within the analytic dataset. The code key linking identities to study codes is stored separately by the PI in secure, locked storage.
Data Management Coded data from REDCap and accelerometers are exported to a secure institutional OneDrive project folder. Only authorized research team members have access. Data integrity is monitored through routine checks for completeness, timestamp accuracy, and device-return compliance. Any discrepancies are documented and resolved prior to analysis.
Statistical Approach
Data analysis will follow these steps:
Exploratory analyses
Sensitivity analyses for missing data or partial adherence.
Sample Size Considerations The study aims to recruit approximately 30 intervention participants and 30 controls across multiple course iterations. This sample size is considered feasible and adequate for detecting meaningful changes in key behavioral and psychosocial measures based on effect sizes reported in previous SCI health-behavior studies. Recruitment continues until target numbers are achieved.
Participant Flow and Adherence Tracking Adherence to program components (session attendance, assignment completion) is recorded through weekly logs maintained by the course leader. Completion of T1-T2-T3 assessments is monitored through REDCap timestamps. Dropout or non-completion is documented with reason if provided.
Ethical and Data-Protection Procedures
All participants provide written informed consent prior to data collection. The intervention is voluntary and declining research participation does not restrict course participation.
All handling of personal data complies with GDPR and institutional policies. Risks are minimal, limited to potential discomfort reflecting on lifestyle habits or wearing an activity monitor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants assigned to this arm take part in the 10-week DRIV web-based health-promotion program. The course consists of weekly 1-hour group video sessions led by a trained course leader. Each week covers a specific lifestyle-related topic relevant to people living with spinal cord injury (e.g., adapted physical activity, healthy eating, stress management, recovery, motivation, and habit formation). Sessions include presentations, guided discussions, and opportunities for peer support. Participants set a personal health goal at baseline and complete weekly home exercises-such as self-monitoring behaviors or practicing course strategies-to reinforce learning between sessions.
Other names: Arm 1 Intervention
Time frame: Baseline to 10 weeks
Physical activity intensity and duration measured using a 7-day wrist accelerometer at baseline and after the 10-week intervention. Values will be summarized as average daily minutes of moderate-to-vigorous physical activity.nt is conducted six months after the program to evaluate sustained effects.
Time frame: Baseline to 10 weeks
Self-reported changes in diet, physical activity, sleep, stress, and tobacco/alcohol use using national public-health lifestyle indicator questions. Scores will be summarized as change from baseline.
Time frame: Baseline to 10 weeks
Self-reported satisfaction with general well-being, physical health, and psychological health on a 0-10 scale. Higher scores indicate better well-being. Reported as the change from baseline.
Time frame: 10 weeks to 6 months
Sustained change in lifestyle behaviors and well-being at 6-month follow-up using the same questionnaires as above.
Time frame: Baseline to 10 weeks
Self-reported body weight measured at home in kilograms. Reported as change from baseline
Karolinska Institutet
Other
DRIV - Health Online for People With a Spinal Cord Injury
Acronym: DRIV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07678437
Central Nervous System Diseases, Nervous System Diseases
Omaha, Nebraska, United States
View Trial DetailsNCT02769416
Brain Diseases, Brain Injuries
Houston, Texas, United States
View Trial DetailsNCT05921487
Body Weight, Central Nervous System Diseases
Syracuse, New York, United States
View Trial DetailsNCT07030322
Central Nervous System Diseases, Nervous System Diseases
San Rafael, California, United States
View Trial Details